68001-535 : Pemetrexed 100 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC68001-535
Labeler: Bluepoint Laboratories
Product Type: Human Prescription Drug
Drug Name:  Pemetrexed
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: ANDA214632
Rev. Date: 


NDC Package Codes:

  • 68001-535-41: 1 VIAL IN 1 CARTON (68001‑535‑41) > 4 ML IN 1 VIAL

Active Ingredients:

  • Pemetrexed Disodium Hemipentahydrate

Dosage Strength:

  • 100 mg/4mL

Pharmaceutical Classes:

  • Folate Analog Metabolic Inhibitor [EPC]
  • Folic Acid Metabolism Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 68001-536 Pemetrexed 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-537 Pemetrexed 1000 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-538 Pemetrexed 100 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-539 Pemetrexed 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-543 Pemetrexed 100 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-544 Pemetrexed 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-545 Pemetrexed 750 mg/30ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-546 Pemetrexed 1000 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-547 Pemetrexed 100 mg/4ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-548 Pemetrexed 500 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-549 Pemetrexed 1 g/40ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-550 Pemetrexed 100 mg/4ml Intravenous Injection, Solution by Bluepoint Laboratories
  • 68001-551 Pemetrexed 500 mg/20ml Intravenous Injection, Solution by Bluepoint Laboratories
  • 68001-552 Pemetrexed 850 mg/34ml Intravenous Injection, Solution by Bluepoint Laboratories
  • 68001-553 Pemetrexed 1000 mg/40ml Intravenous Injection, Solution by Bluepoint Laboratories
  • 0338-0720 Pemetrexed 100 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0338-0722 Pemetrexed 500 mg/50ml Intraventricular Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0409-0004 Pemetrexed 1 g/40ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-0020 Pemetrexed 100 mg/4ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 0409-0021 Pemetrexed 500 mg/20ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 68001-535 QR Code

< Prev: 68001-534Next: 68001-536 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.